These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13741382)

  • 41. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis.
    Mösges R; Bachert C; Rudack C; Hauswald B; Klimek L; Spaeth J; Rasp G; Vent J; Hörmann K
    Adv Ther; 2011 Mar; 28(3):238-49. PubMed ID: 21318604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis.
    Yonezaki M; Akiyama K; Karaki M; Goto R; Inamoto R; Samukawa Y; Kobayashi R; Kobayashi E; Hoshikawa H
    Auris Nasus Larynx; 2016 Jun; 43(3):292-7. PubMed ID: 26498699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients With Severe to Extreme Anatomical Nasal Obstruction.
    Teti VP; Akdagli S; Most SP
    JAMA Facial Plast Surg; 2016 May; 18(3):165-70. PubMed ID: 26747790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Endonasal synthetic oxytocin: its clinical use].
    MAGLI G
    Riv Ostet Ginecol Prat; 1960 Apr; 42():309-15. PubMed ID: 14419860
    [No Abstract]   [Full Text] [Related]  

  • 46. [Survey of sensory perception and patients' subjective assessment of the application of nasal sprays - the nasal-spray-sensoric-scale].
    Mösges R; Pasch N; Sayar A; Schmalz P; Vent J
    Laryngorhinootologie; 2009 Sep; 88(9):587-91. PubMed ID: 19294613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray.
    Rajpal S; Morris LA; Akkus NI
    Rev Port Cardiol; 2014 Jan; 33(1):51.e1-4. PubMed ID: 24405558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effectiveness of genetic nasal spray of fluticasone propionate ester].
    Watanabe N; Nakagawa T; Makino S
    Arerugi; 2013 Aug; 62(8):986-8. PubMed ID: 24919221
    [No Abstract]   [Full Text] [Related]  

  • 49. Metoclopramide nasal spray in vitro evaluation and in vivo pharmacokinetic studies in dogs.
    Li Y; Fan X; Li W; Yang P; Zhang H; Tang D; Yin X; Sun J; Zheng A
    Pharm Dev Technol; 2018 Mar; 23(3):275-281. PubMed ID: 28379057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of a novel nasal spray for maxillary dental anesthesia.
    Ciancio SG; Hutcheson MC; Ayoub F; Pantera EA; Pantera CT; Garlapo DA; Sobieraj BD; Almubarak SA
    J Dent Res; 2013 Jul; 92(7 Suppl):43S-8S. PubMed ID: 23690356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of azelastine nasal spray on nasal and nasopharyngeal microflora.
    Aksoy F; Senturk E; Doğan R; Veyseller B; Ozturan O; Gönüllü N; Yilmaz F
    J Laryngol Otol; 2016 Jan; 130(1):95-9. PubMed ID: 26515526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An overlooked Rx for nasal obstruction relief.
    Leventhal WD
    J Fam Pract; 2017 Mar; 66(3):135. PubMed ID: 28249059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketorolac nasal spray--a new formulation of this non-narcotic pain reliever.
    Wynn RL
    Gen Dent; 2012; 60(2):90-2. PubMed ID: 22414499
    [No Abstract]   [Full Text] [Related]  

  • 54. A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion.
    Bhargava R; Chakravarti A
    Am J Otolaryngol; 2014; 35(6):766-70. PubMed ID: 25151658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients.
    Emanuel IA; Blaiss MS; Meltzer EO; Evans P; Connor A
    Am J Rhinol Allergy; 2014; 28(2):117-21. PubMed ID: 24598007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast-feeding and maternal health in online mothers.
    Mezzacappa ES; Guethlein W; Katkin ES
    Ann Behav Med; 2002; 24(4):299-309. PubMed ID: 12434941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
    Yuta A; Ogawa Y
    Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of topical sprays on allergy-induced nasal obstruction in children.
    Yaşar M; Uysal IÖ; Altuntaş EE; Cevit Ö; Müderris S
    Kulak Burun Bogaz Ihtis Derg; 2013; 23(4):217-24. PubMed ID: 23834132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxytocin selectively modulates brain processing of disgust in Huntington's disease gene carriers.
    Labuschagne I; Poudel G; Kordsachia C; Wu Q; Thomson H; Georgiou-Karistianis N; Stout JC
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():11-16. PubMed ID: 28947180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A modified USP induction port to characterize nasal spray plume geometry and predict turbinate deposition under flow.
    Moraga-Espinoza D; Warnken Z; Moore A; Williams RO; Smyth HDC
    Int J Pharm; 2018 Sep; 548(1):305-313. PubMed ID: 29960037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.